Tiotropium bromide (soft mist inhaler): brand names and study card
Tiotropium bromide (soft mist inhaler) — Long-acting muscarinic antagonist (LAMA). Study the mechanism, listed uses and warnings from the US label on one sourced card.
Label date: 20260817 · For learning, not clinical decisions. US label and brand information; always consult the current source.
Source snapshot checked: 2026-10-21. The source document and selected fields were compared. The complete card has not had an independent clinical review.
Mechanism: A synthetic trifluorinated corticosteroid with anti-inflammatory activity. High glucocorticoid-receptor binding affinity is shown in vitro, but its clinical significance and the precise mechanism of rhinitis symptom relief are unknown.
On both cards: Common side effects — Pharyngitis; Cough; Headache
Only on the Fluticasone card: Used for — Nasal symptoms of perennial nonallergic rhinitis in adults and children aged 4 or older · Common side effects — Epistaxis; Nasal burning / irritation · Warnings — Epistaxis, nasal ulceration, septal perforation; Glaucoma and cataracts; Hypercorticism and adrenal suppression · Interactions — Strong CYP3A4 inhibitors (e.g. ritonavir, ketoconazole)
Mechanism: Binds with high affinity and selectivity to the CysLT1 receptor, inhibiting physiologic actions of leukotriene D4 in the airway.
On both cards: Common side effects — Pharyngitis; Cough; Headache
Only on the Montelukast card: Used for — Asthma prophylaxis and chronic treatment in patients aged 15 years and older; Prevention of exercise-induced bronchoconstriction in patients aged 15 years and older; Seasonal or perennial allergic rhinitis in patients aged 15 years and older only when alternative therapies are ineffective or not tolerated · Common side effects — Upper respiratory infection; Fever · Warnings — Not for acute asthma attacks; Systemic eosinophilia / Churg-Strauss; Aspirin sensitivity persists
Mechanism: A synthetic trifluorinated corticosteroid with anti-inflammatory activity and high glucocorticoid-receptor affinity in vitro. It affects inflammatory cells and mediators, but the precise mechanism of rhinitis symptom relief and the clinical significance of receptor-binding findings are unknown.
On both cards: Common side effects — Pharyngitis; Cough; Headache
Only on the Fluticasone propionate card: Used for — Nasal symptoms of perennial nonallergic rhinitis in adults and children aged 4 or older · Common side effects — Epistaxis; Nasal burning / irritation · Warnings — Epistaxis, nasal ulceration, septal perforation; Glaucoma and cataracts; Hypercorticism / adrenal suppression · Interactions — Strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole)
An item counts as shared only when both cards use the same wording. If a card does not list an item, that is not a statement that the effect never occurs.
Capsera